Scopus BioPharma Inc.
SCPSDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001772028
Scopus BioPharma Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Nov 26, 2021; 15 institutions reported holding it in 13F filings for Q3 2022, worth $110.6K in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Scopus BioPharma Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 17 | 15 | −2 |
| Shares | 686.7K | 465.9K | −220.8K (−32.2%) |
| Value | $293.0K | $110.6K | −$182.4K (−62.2%) |
New holders (2)
Institutions that held Scopus BioPharma Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Y-Intercept (Hong Kong) Ltd | 10,940 | $2.65K | 0.00% |
| Morgan Stanley | 2 | $0 | 0.00% |
Sold out (4)
Institutions that held Scopus BioPharma Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Vanguard Group Inc | 54,649 | $24.0K |
| Bridgeway Capital Management, LLC | 32,966 | $14.0K |
| Goldman Sachs Group Inc | 17,405 | $7.00K |
| Royal Bank of Canada | 1,000 | $0 |